25 May 2013
Keywords: receptagen, begins, growth, blocker, trials, begun, first
Article | 27 February 1995
Receptagen has begun the first clinical trials of a lead compound in its second drug development program, growth blockers. Recent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.